We found that the expression pattern of glutamine metabolism-related genes was closely associated with their IDH mutational status, but a significant distinction in tumor aggressiveness and TME profile persisted in both IDH-mutants and IDH-wildtype gliomas. The gene discussed is IDH1; the disease is neoplasm.